• 1. Evolving better nanoparticles: Genetic algorithms for optimising cluster geometries
  Dalton Trans., 2003, 4193-4207
• 2. Estimates of hydride ion stability in condensed systems: energy of formation and solvation in aqueous and polar-organic solvents
  Craig A. Kelly,David R. Rosseinsky Phys. Chem. Chem. Phys., 2001,3, 2086-2090
• 3. Evolution of calcium phosphate precipitation in hanging drop vapor diffusion by in situRaman microspectroscopy
  Gloria Belén Ramírez-Rodríguez,José Manuel Delgado-López,Jaime Gómez-Morales CrystEngComm, 2013,15, 2206-2212
• 4. Enabling shape memory and healable effects in a conjugated polymer by incorporating siloxane via dynamic imine bond?
  Yaling Zhang,Chunhui Dai,Shiwei Zhou,Bin Liu Chem. Commun., 2018,54, 10092-10095
• 5. Evolution in surface coverage of CH3NH3PbI3?XClXvia heat assisted solvent vapour treatment and their effects on photovoltaic performance of devices
  Dhirendra K. Chaudhary,Pramendra Kumar,Lokendra Kumar RSC Adv., 2016,6, 94731-94738

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Benzyl halides

Introduction to 4-(Fluoromethyl)phenol (CAS No. 62037-85-8)

4-(Fluoromethyl)phenol, chemically designated as CAS No. 62037-85-8, is a significant compound in the realm of organic chemistry and pharmaceutical research. This compound, featuring a fluoromethyl group attached to a phenol ring, has garnered considerable attention due to its versatile applications and potential in the development of novel therapeutic agents. The unique structural properties of 4-(Fluoromethyl)phenol make it a valuable intermediate in synthetic chemistry, particularly in the synthesis of complex molecules that are integral to modern medicinal chemistry.

The fluoromethyl moiety in 4-(Fluoromethyl)phenol is particularly noteworthy, as fluorine-containing compounds are widely recognized for their enhanced metabolic stability, improved bioavailability, and altered pharmacokinetic profiles. These attributes have made fluorinated derivatives indispensable in the pharmaceutical industry. In recent years, there has been a surge in research focused on leveraging the benefits of fluorine substitution to develop more effective and targeted drugs. The phenol ring, on the other hand, provides a hydroxyl functional group that can participate in various chemical reactions, including esterification, etherification, and oxidation processes, thereby facilitating the synthesis of a wide array of derivatives.

Recent advancements in the field of medicinal chemistry have highlighted the importance of 4-(Fluoromethyl)phenol in the development of innovative drug candidates. For instance, studies have demonstrated its utility as a precursor in the synthesis of fluorinated aromatic compounds that exhibit significant antimicrobial and anti-inflammatory properties. These findings underscore the compound's potential as a building block for next-generation therapeutics. Moreover, the growing interest in fluorinated compounds has led to the exploration of novel synthetic pathways that enhance the efficiency and scalability of producing 4-(Fluoromethyl)phenol.

The chemical properties of 4-(Fluoromethyl)phenol also make it a compelling candidate for use in material science applications. Fluorinated aromatic compounds are known for their high thermal stability and resistance to degradation, which are critical attributes for materials used in harsh environments. Researchers have been investigating its incorporation into polymers and coatings to improve durability and performance. Additionally, the compound's ability to undergo selective functionalization has opened up possibilities for designing advanced materials with tailored properties.

In terms of biological activity, 4-(Fluoromethyl)phenol has shown promise in preliminary studies as a modulator of various biological pathways. The presence of both the fluoromethyl and phenol groups allows for interactions with biological targets that could lead to therapeutic effects. For example, derivatives of this compound have been explored for their potential role in inhibiting enzymes involved in inflammatory responses. While further research is needed to fully elucidate its biological mechanisms, these initial findings highlight its significance as a lead compound in drug discovery efforts.

The synthesis of 4-(Fluoromethyl)phenol typically involves multi-step organic reactions that require careful optimization to achieve high yields and purity. Common synthetic routes include Friedel-Crafts alkylation followed by reduction or direct fluorination techniques. The choice of methodology often depends on factors such as cost-effectiveness, scalability, and environmental considerations. Recent innovations in synthetic chemistry have aimed at developing more sustainable and efficient protocols for producing this compound, aligning with global efforts to minimize chemical waste and reduce environmental impact.

The industrial production of 4-(Fluoromethyl)phenol is also influenced by regulatory considerations and quality control measures. Ensuring that the final product meets stringent purity standards is essential for its application in pharmaceuticals and other high-value industries. Manufacturers must adhere to Good Manufacturing Practices (GMP) and other regulatory guidelines to guarantee consistency and safety. As demand for fluorinated compounds continues to rise, there is an increasing focus on developing robust supply chains that can meet these requirements efficiently.

Looking ahead, the future prospects for 4-(Fluoromethyl)phenol are promising, given its diverse applications and potential for further innovation. Ongoing research efforts are expected to yield new insights into its chemical behavior and biological effects, paving the way for novel applications across multiple sectors. Whether used as a key intermediate in drug development or as a component in advanced materials, this compound continues to play a pivotal role in advancing scientific knowledge and technological progress.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)